Business

Chemed Says Vitas Projects $18 Million -$25 Million Medicare Cap Revenue Limitation For 2025 - SEC Filing

Chemed Says Vitas Projects $18 Million -$25 Million Medicare Cap Revenue Limitation For 2025 - SEC Filing

Medicare Group QscJune 27, 20254
Chemed Says Vitas Projects $18 Million -$25 Million Medicare Cap Revenue Limitation For 2025 - SEC Filing

About this update from Medicare Group Qsc

Chemed Corp NYSE:CHE:CHEMED CORP - VITAS PROJECTS $18M-$25M MEDICARE CAP REVENUE LIMITATION FOR 2025 - SEC FILING

View stock analysis, news, and events for Medicare Group Qsc